🟢 Icecure Medical is trading 13.3% up in pre-market with no clear catalyst identified

Icecure Medical is trading at $1.13, up +13.28%, in pre-market; no clear catalyst has been identified.

• No new company-specific announcement dated October 23 was identified in the available search results.
• The latest company release found was October 20, reporting enrollment of the first two patients in its ChoICE study; that earlier update does not establish the reason for the move.
• U.S. futures were described as mixed, and available evidence does not clearly tie the rise to broader market sentiment.